At Biogen, our mission is clear : we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases
The Rare Disease Account Executive (RDAE) main responsibility is to drive patient identification (not contact) and market development for SMA by creating territory, account and customer strategies to achieve area sales, market share and profit targets for their territory.
Furthermore, effectively maintaining relationships with physicians and treatment clinics to properly educate on SPINRAZA and remove barriers to facilitate healthcare provider decisions.
The RDAE is accountable for the success of SPINRAZA in the assigned accounts by working in partnership with marketing, logistics support, internal / field market access and medical colleagues to create value for patients and other relevant stakeholders within the accounts to ensure long-term growth in alignment with Biogen s code of conduct and the strictest ethical, compliance and legal standards.
Establish clinical value of SPINRAZA instilling a sense of urgency to treat SMA.
Achieve intimate knowledge of the accounts stakeholders’ priorities and decision making processes (patient flow identification / selection, choice of therapeutic options, budget allocation, and care coordination, business needs, drivers and barriers for SPINRAZA utilization).
30-40% of their time traveling